How to Become a Psychedelic Practitioner in Europe
Updated for 2027
In short: There is no single European pathway to becoming a psychedelic practitioner. Your route will depend on your professional background, the kind of work you want to do, the country you practise in, and the legal and professional framework that applies to that role.
Interest in psychedelics is growing across Europe.
Research continues to develop. New models of care are being explored. Regulatory conversations are changing. And more therapists, healthcare professionals, coaches and others are asking how they can responsibly become involved in this emerging field.
But there is no single answer to the question: how do I become a psychedelic practitioner?
There is currently no single Europe-wide training pathway or professional qualification that makes someone a “psychedelic practitioner”. What you can responsibly and legally do depends on your existing professional background, where you live and work, the setting you practise within, and the type of support you intend to provide.
That distinction is important.
Psychedelic practitioner training can deepen your knowledge, practical skills and capacity to support people around psychedelic experiences. It does not automatically qualify you as a therapist, psychologist, psychiatrist or healthcare professional, nor does it override the professional or legal requirements that apply within your country.
So rather than starting only with the question “Which psychedelic course should I take?”, it may be more useful to ask:
What role do I hope to play in this field, and what knowledge, experience and professional foundations will I need to hold that role responsibly?
What is a psychedelic practitioner?
“Psychedelic practitioner” is a broad term rather than a single regulated profession.
It may describe someone supporting people before, during or after psychedelic experiences. It can also describe someone bringing an understanding of psychedelics and altered states into an existing professional practice.
That means psychedelic practitioners can come from very different backgrounds.
A psychiatrist exploring psychedelic-assisted treatment pathways has different responsibilities from a psychologist providing integration support. A counsellor or coach may work with clients who have had psychedelic experiences without administering psychedelics themselves. A facilitator working within a retreat setting occupies another role again.
What connects these roles is not necessarily a shared professional title. It is the need to understand the particular responsibilities that arise when working with altered states, vulnerability, power and experiences that can carry considerable psychological and emotional intensity.
This is one reason ETI’s training brings together psychiatrists, psychologists and counsellors alongside doctors, nurses, other healthcare professionals, coaches, wellbeing practitioners, students and trainees. ETI | 2027 Webinar
Do you need to be a therapist or healthcare professional?
Not necessarily.
There are meaningful roles around psychedelic experiences that do not require someone to become a psychologist, psychotherapist, psychiatrist or doctor. Preparation, integration, coaching, education, harm reduction, peer support and some forms of facilitation can exist outside formal psychotherapy.
But your existing qualifications still matter.
If you are providing psychotherapy, diagnosing mental health conditions or delivering medical treatment, you need the appropriate professional training and authorisation to do so. Completing a psychedelic practitioner training programme does not replace those requirements.
For someone without a clinical background, the question becomes less about acquiring permission to “do therapy” and more about understanding your scope of practice.
What are you competent to offer? Where are the edges of that competence? What should you refer onwards? What happens when someone presents with needs that exceed the support you can safely provide?
Knowing where your role ends is as important as developing the skills to work within it.
Psychedelic practitioner, facilitator or therapist: what is the difference?
Language within the psychedelic field can become confusing because terms are sometimes used interchangeably when they may involve quite different responsibilities.
RoleWhat it might involveImportant distinctionPsychedelic practitioner or facilitatorPreparation, facilitation, integration, education or support around psychedelic experiencesA broad description that does not itself confer a clinical qualificationTherapist, counsellor or psychologistSupporting clients within an established therapeutic relationship and professional scopePsychedelic training supplements rather than replaces their core professional trainingMedical or psychiatric professionalAssessment, diagnosis, prescribing or treatment within an established healthcare roleGoverned by the professional and regulatory requirements of that rolePsychedelic-assisted treatment providerDelivering psychedelic treatment within a formal healthcare pathwayRequirements depend on the treatment, profession, jurisdiction and regulatory framework
These distinctions are likely to become increasingly important as psychedelic-assisted healthcare develops.
What should psychedelic practitioner training involve?
Working responsibly with psychedelics involves much more than understanding what happens during a psychedelic experience.
The experience itself sits within a much wider process.
At ETI, we think about this as the full arc of psychedelic facilitation, beginning with screening and preparation, moving through the psychedelic experience itself, and continuing into immediate and prolonged integration. Running throughout that arc are considerations around safety, ethics, consent, boundaries and transference. ETI | 2027 Webinar
Good practitioner training should therefore build understanding across areas such as psychedelic substances and altered states; screening and intake; preparation and intention setting; ethics, consent and boundaries; facilitation; challenging experiences; immediate and prolonged integration; relational dynamics; referral and scope of practice; and ongoing supervision, intervision and reflective learning.
ETI’s 2027 Education Module reflects this breadth. Across 20 live online sessions, participants explore psychedelics and psilocybin, screening and intake, preparation, constellations, psychodrama and IFS, ethics and boundaries, dosing-day support, challenging experiences, integration, starting a practice, case studies and the future of the field. The programme also uses intervision, role play, breakout work and scenario planning rather than relying on lectures alone. ETI | 2027 Webinar
The aim is not simply to accumulate information.
It is to develop judgement.
What kind of knowledge should psychedelic training draw from?
Psychedelic practice sits at the meeting point of several different forms of knowledge.
A responsible training programme should engage seriously with the latest scientific research and evidence. Practitioners need to understand what clinical studies are showing, where evidence remains limited or uncertain, what is known about risks and contraindications, and how scientific understanding of different substances and approaches continues to evolve.
This means being evidence-informed without treating emerging findings as settled fact.
Research is also only one part of the picture.
Some psychedelic substances and practices have histories of ceremonial, spiritual and community use extending far beyond their relatively recent investigation within Western medicine. The European Union Drugs Agency notes longstanding ritual and religious uses of substances including DMT-containing preparations and mescaline within particular Indigenous and non-Indigenous traditions. European Union Drugs Agency
There can be value in learning from these traditions and the perspectives they hold, while remaining thoughtful about cultural context, appropriation and the limitations of transplanting practices from one setting into another.
And there is lived and experiential knowledge.
What does an altered state actually feel like? What happens when someone feels frightened or overwhelmed? What is it like to relinquish control, encounter something deeply meaningful, depend on another person for support, or return to ordinary life carrying an experience that might take months to understand?
At ETI, we are interested in what becomes possible when different forms of knowledge are held alongside one another: current scientific evidence, psychological understanding, traditional and ceremonial perspectives, and lived experience.
None needs to be treated as the complete answer.
Together, they can provide a more holistic perspective on both the potential of psychedelics and the responsibilities involved in working with them.
Why experiential learning matters
Psychedelic work presents an unusual challenge for education.
There are things we can understand intellectually about altered states and things that may be much harder to appreciate until we encounter vulnerability, uncertainty, emotion or significant shifts in perception ourselves.
This is why experiential learning sits at the centre of ETI’s approach.
We think about our training as practical, relational, holistic, experiential and personal. ETI | 2027 Webinar
Within the Core Practitioner Training, the Education Module is therefore combined with an Experiential Retreat in the Netherlands. Participants move between the participant and facilitator roles within a carefully held group environment. ETI | 2027 Webinar
This does not mean that having a psychedelic experience makes someone competent to facilitate one.
Personal experience is not a substitute for professional skill.
Instead, experiential learning can offer another layer of understanding: what vulnerability feels like from the inside, how much influence a facilitator can carry, what it means to trust another person while in a non-ordinary state, and why consent, boundaries and relational awareness matter so much.
The learning also does not end when the psychedelic experience ends. ETI’s experiential model incorporates preparation before the retreat and integration and feedback afterwards, placing the four days themselves within a longer process. ETI | 2027 Webinar
What should you look for in psychedelic practitioner training?
As interest in psychedelics grows, so does the range of training available.
Look beyond the number of lectures or the promise of a certificate.
A responsible programme should be transparent about what it prepares you to do and what it does not.
Consider the professional and experiential backgrounds of the people teaching you. Look at how seriously the programme treats screening, safety, ethics, consent and boundaries. Ask what happens when somebody has a challenging experience, how experiential components are held, what safeguarding structures exist and whether there is meaningful opportunity for feedback and reflection.
Look for training that engages with current research while remaining open about uncertainty and the limits of the evidence.
And consider the relational aspects of the work. How does the programme address power, transference, vulnerability and the influence a practitioner may hold when another person is in an altered state?
It is also worth asking whether the training primarily teaches techniques, or whether it develops the capacity to respond to complexity.
Psychedelic experiences can be profound, confusing, joyful, frightening, beautiful, destabilising, mundane or difficult to interpret. A responsible practitioner needs to be able to meet that range without rushing to impose meaning on another person’s experience.
How is psychedelic regulation developing across Europe?
There is no single European legal framework governing psychedelic practice.
National laws differ, professional regulations differ, and healthcare systems approach medicines and psychological treatment differently. The European Union Drugs Agency advises checking relevant national authorities because the legal status of these substances and practices varies between countries and can change over time. European Union Drugs Agency
The European landscape is also broader than formal healthcare.
The EUDA has identified growth in psychedelic-related practices associated with wellness, therapeutic and spiritual contexts across Europe, including retreats, while noting that evidence about the scale, safety and nature of many of these practices remains limited. European Union Drugs Agency
Clinical research is developing alongside this wider landscape. Psilocybin has been studied for conditions including treatment-resistant depression and major depressive disorder, while much of the clinical development around MDMA has focused on post-traumatic stress disorder. European Union Drugs Agency
For practitioners, this means training should not be treated as a passport that allows someone to practise in the same way across Europe.
Professional scope and local regulation still matter.
A field that may look very different in ten years
Anyone beginning psychedelic practitioner training today is entering a field in transition.
The United States offers one particularly visible example of how quickly the surrounding research and regulatory environment can change.
In April 2026, a US Executive Order directed federal agencies to accelerate research and appropriate regulatory pathways for psychedelic drugs being investigated for serious mental illness. The order included measures relating to priority review, research collaboration and regulatory processes. It did not itself approve psychedelic medicines or remove the requirement for evidence of safety and efficacy. The White House
In July 2026, the US Food and Drug Administration also finalised dedicated guidance for companies conducting clinical investigations of psychedelic drugs, reflecting the particular methodological and safety questions involved in developing these treatments. U.S. Food and Drug Administration
At the same time, several late-stage development programmes have moved closer to possible regulatory decisions.
COMPASS Pathways has reported positive Phase 3 results for COMP360, its proprietary synthetic psilocybin formulation being investigated for treatment-resistant depression (TRD). As of September 2026, a rolling New Drug Application review was under way, with the company expecting to complete its submission in the fourth quarter of 2026. Any commercial use remains dependent on FDA approval and subsequent regulatory steps. Compass Pathways
The pathway for MDMA-assisted therapy for PTSD has been less straightforward. Following the FDA's rejection of the original application in 2024, MAPS reported in August 2026 that Resilient Pharmaceuticals, formerly Lykos Therapeutics, had resubmitted a New Drug Application for MDMA-assisted therapy for PTSD. This begins another regulatory evaluation rather than constituting an approval. MAPS
What happens in the United States will not automatically determine what happens in Europe.
Different countries have different medicines regulators, healthcare systems, professional standards and legal frameworks.
But developments of this scale could influence the wider conversation: the evidence available to regulators, how psychedelic treatments are designed, which professional competencies might be required, how practitioners are trained and supervised, and how countries consider integrating psychedelic approaches into existing systems of care.
For someone entering the field now, this creates an unusual challenge.
Training needs to prepare practitioners for the landscape that exists today, while developing enough judgement, adaptability and professional grounding to work within a field that may change substantially over the decade ahead.
So, how do you become a psychedelic practitioner?
A useful starting point is not choosing a job title.
It is understanding the role you hope to occupy.
If you already work as a psychologist, psychiatrist, therapist, counsellor, doctor, nurse or other healthcare professional, psychedelic education may become an additional layer of knowledge alongside your existing training and professional responsibilities.
If you come from coaching, wellbeing or another non-clinical background, your pathway may focus more heavily on facilitation, preparation, integration or other forms of non-clinical support.
And if you are at the beginning of your career, psychedelic practitioner education may help you understand the field while you continue developing the professional foundations required for the role you ultimately hope to hold.
In each case, responsible practice involves more than completing a training programme.
It asks for continued learning, supervision or intervision, self-reflection, attention to professional scope, engagement with evolving evidence, connection with peers and a willingness to recognise the limits of what you know.
ETI’s approach to Psychedelic Practitioner Training
At the Experiential Training Institute, our work is grounded in the idea of being in relation.
Our approach brings together Western psychological perspectives and learning from psychedelic ceremonial contexts within a model that seeks to be holistic, relational and attentive to mind, body, heart and meaning. ETI | 2027 Webinar
For 2027, our Core Practitioner Training combines 20 live online Education sessions across two semesters with a four-day Experiential Retreat in the Netherlands. ETI | 2027 Webinar
The Education Module covers the full arc of facilitation, while the retreat gives participants the opportunity to bring that learning into lived practice. The programme then sits within a wider practitioner community, currently connecting more than 120 people across over 20 countries. ETI | 2027 Webinar
Importantly, completing the Core Programme is not a licence to practise psychedelic-assisted therapy, nor does it replace any clinical qualification, professional registration or legal authorisation required in the country where you work.
Instead, we see training as one part of a much longer process of developing the knowledge, practical skill, embodied understanding and self-awareness required to approach this work responsibly.
Frequently asked questions
Can anyone become a psychedelic practitioner?
There is no single European qualification defining a psychedelic practitioner. People enter the field from many professional backgrounds, but the work they can responsibly offer depends on their training, competence, existing professional scope and local legal framework.
Do I need to be a therapist to undertake psychedelic practitioner training?
Not necessarily. ETI welcomes people from clinical and non-clinical backgrounds, including healthcare professionals, counsellors, coaches, wellbeing practitioners, students and trainees. Different backgrounds will, however, lead to different scopes of practice.
Does psychedelic practitioner training qualify me to provide psychedelic-assisted therapy?
No. Practitioner training should not be understood as a replacement for psychotherapy, psychology, psychiatry or healthcare qualifications where those are required to provide a particular form of treatment.
Should psychedelic training be evidence-based?
We believe training should be informed by the best available evidence, while remaining honest about where research is still emerging.
Scientific research is essential for understanding efficacy, risk, contraindications and clinical applications. But responsible practice can also benefit from psychological knowledge, lived experience, relational learning and thoughtful engagement with the cultural and ceremonial contexts in which some psychedelic practices have developed.
The challenge is not to collapse these different forms of knowledge into one another, but to learn what each can contribute.
Do I need personal psychedelic experience?
Different training programmes take different approaches.
At ETI, first-hand experiential learning forms part of the Core Programme because we believe this work involves more than theoretical knowledge alone. Experiential learning takes place within a structured training environment and is accompanied by preparation, facilitation, integration and feedback.
Personal experience itself should never be confused with professional competence.
How long does psychedelic practitioner training take?
There is no standard European training length.
ETI’s 2027 Core Programme runs across approximately eight months, combining two semesters of online education with an in-person Experiential Retreat in the Netherlands.
What happens after training?
Learning should not stop with certification.
Continued development may include supervision or intervision, case discussion, further education, reflective practice, staying up to date with emerging research and regulation, and ongoing connection with a professional community.
Beginning your journey
Psychedelic practice is still an evolving field.
That makes curiosity valuable, but it also makes humility essential.
The question is not simply how quickly someone can become a psychedelic practitioner.
It is how we develop the knowledge, experience, self-awareness and professional grounding required to meet another person responsibly in what can be one of the most vulnerable and meaningful experiences of their life.
And how we continue learning as the field itself changes around us.
